A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

NCT01001104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2189265
DRUG: Placebo

Sponsor

Eli Lilly and Company